Mesoblast (MESO) had the highest return between 1980 and 2025 by a US stock in the Biotechnology Industry, returning 18,039,900%.
| ASSET | YEARS | % RETURN |
|---|---|---|
Mesoblast (MESO) | 1980-2025 | 18,039,900% |
Forte Biosciences (FBRX) | 1980-2025 | 2,097,592.31% |
Avita Medical (RCEL) | 1980-2025 | 862,400% |
MDxHealth SA ADR (MDXH) | 1980-2025 | 396,566.67% |
Medicus Pharma Ltd Common Stock (MDCX) | 1980-2025 | 218,471.43% |
Immatics (IMTX) | 1980-2025 | 209,900% |
Evogene (EVGN) | 1980-2025 | 157,042.86% |
Amgen (AMGN) | 1980-2025 | 139,659% |
Lexaria Bioscience (LEXX) | 1980-2025 | 138,034.33% |
Altimmune (ALT) | 1980-2025 | 124,382.76% |
Gilead Sciences (GILD) | 1980-2025 | 32,670.27% |
Lixte Biotechnology (LIXT) | 1980-2025 | 26,100% |
Vertex Pharmaceuticals (VRTX) | 1980-2025 | 9,836.66% |
United Therapeutics (UTHR) | 1980-2025 | 7,118.41% |
MiMedx (MDXG) | 1980-2025 | 6,670% |
Regencell Bioscience (RGC) | 1980-2025 | 6,549.78% |
Alnylam Pharmaceuticals (ALNY) | 1980-2025 | 6,418.85% |
Biogen (BIIB) | 1980-2025 | 5,766.33% |
Incyte (INCY) | 1980-2025 | 5,167.73% |
Azitra (AZTR) | 1980-2025 | 4,632.14% |
argenx NV ADR (ARGX) | 1980-2025 | 4,598.04% |
Regeneron Pharmaceuticals (REGN) | 1980-2025 | 3,427.96% |
Alaunos Therapeutics (TCRT) | 1980-2025 | 2,976.19% |
Krystal Biotech (KRYS) | 1980-2025 | 2,248% |
Insmed (INSM) | 1980-2025 | 2,009.58% |